• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials.

作者信息

Kheiri Babikir, Simpson Timothy F, Stecker Eric C, Osman Mohammed, Rahmouni Hind, Zahr Firas, Nazer Babak, Cigarroa Joaquin E

机构信息

Knight Cardiovascular Institute, UHN-62, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR, 97239, USA.

Division of Cardiology, West Virginia University School of Medicine, Morgantown, WV, USA.

出版信息

J Thromb Thrombolysis. 2020 Aug;50(2):395-398. doi: 10.1007/s11239-020-02041-7.

DOI:10.1007/s11239-020-02041-7
PMID:31981041
Abstract
摘要

相似文献

1
Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials.用于稳定型冠状动脉疾病合并心房颤动的抗栓治疗：一项随机对照试验的荟萃分析
J Thromb Thrombolysis. 2020 Aug;50(2):395-398. doi: 10.1007/s11239-020-02041-7.
2
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.心房颤动抗栓治疗指南：了解不依从的原因并推进简化卒中与出血风险分层
Europace. 2010 Jun;12(6):761-3. doi: 10.1093/europace/euq102. Epub 2010 Apr 12.
3
Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.心房颤动伴急性或慢性冠状动脉疾病的口服抗血栓治疗。
Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.
4
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
5
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
6
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.与心房颤动高危患者治疗不足相比，遵循指南的抗栓治疗与改善的结局相关。欧洲心房颤动调查。
Am Heart J. 2007 Jun;153(6):1006-12. doi: 10.1016/j.ahj.2007.03.008.
7
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.应对心房颤动合并冠状动脉疾病患者抗栓治疗的复杂局面：来自AUGUSTUS研究的经验教训
Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.
8
[Antithrombotic treatment of atrial fibrillation].[心房颤动的抗栓治疗]
Can J Cardiol. 1996 Feb;12 Suppl A:14A-18A.
9
Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations.接受经皮冠状动脉介入治疗的心房颤动患者抗血栓治疗管理算法：基于疗效考量的更新建议
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):197-198. doi: 10.1093/ehjcvp/pvaa003.
10
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.双联或三联抗栓治疗患者的出血和缺血结局：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021.

引用本文的文献

1
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis.近期或既往有事件的心房颤动合并冠状动脉疾病患者的抗栓治疗：系统评价和荟萃分析
CJC Open. 2024 Jan 12;6(5):708-720. doi: 10.1016/j.cjco.2024.01.001. eCollection 2024 May.
2
Chinese expert consensus on antithrombotic management of high-risk elderly patients with chronic coronary syndrome.中国老年高危慢性冠状动脉综合征患者抗栓治疗管理专家共识
Aging Med (Milton). 2023 Feb 5;6(1):4-24. doi: 10.1002/agm2.12234. eCollection 2023 Mar.
3
Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
口服抗凝药物双联治疗与单独口服抗凝药物单药治疗用于伴有心房颤动和稳定型缺血性心脏病患者：系统评价和荟萃分析。
J Interv Card Electrophysiol. 2023 Mar;66(2):493-506. doi: 10.1007/s10840-022-01347-1. Epub 2022 Sep 9.
4
The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol.达比加群酯和利伐沙班对氧化胆固醇致血管内皮损伤模型中 DNA 氧化变化的保护作用。
Int J Mol Sci. 2020 Mar 13;21(6):1953. doi: 10.3390/ijms21061953.